This grant by the Immunization and Infectious Diseases Department supports research to evaluate the effectiveness of empiric influenza antiviral therapy alongside antibiotic therapy for hospitalized patients with Community Acquired Pneumonia (CAP) and other lower respiratory tract illnesses during influenza seasons. Aligned with the objectives of FOA IP10-007, this initiative contributes to the ‘Healthy People 2020’ goals, specifically focusing on Immunization and Infectious Diseases. Researchers are urged to investigate the impact of antiviral treatment on CAP patients to enhance treatment protocols and optimize outcomes in the face of influenza virus circulation.
Opportunity ID: 187654
General Information
| Document Type:: | Grants Notice |
| Funding Opportunity Number:: | CDC-RFA-IP10-0070201SUPP12 |
| Funding Opportunity Title:: | Effectiveness of Empiric Antiviral Treatment for Hospitalized Community Acquired Pneumonia during the Influenza Season |
| Opportunity Category:: | Discretionary |
| Opportunity Category Explanation:: | |
| Funding Instrument Type:: | |
| Category of Funding Activity:: | Health |
| Category Explanation:: | |
| Expected Number of Awards:: | |
| Assistance Listings Number(s):: | 93.185 — Immunization Research, Demonstration, Public Information and Education_Training and Clinical Skills Improvement Projects |
| Cost Sharing or Matching Requirement:: | No |
| Version:: | Synopsis 1 |
| Posted Date:: | Jul 30, 2012 |
| Last Updated Date:: | |
| Original Closing Date for Applications:: | Aug 10, 2012 |
| Current Closing Date for Applications:: | Aug 10, 2012 |
| Archive Date:: | Sep 09, 2012 |
| Estimated Total Program Funding:: | $ 846,000 |
| Award Ceiling:: | $0 |
| Award Floor:: | $0 |
Eligibility
| Eligible Applicants:: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility:: | This award will be a continuation of funds intended only for grantee previously awarded under Funding Opportunity Announcement IP10-007, “Effectiveness of Empiric Antiviral Treatment for Hospitalized Community Acquired Pneumonia during the Influenza Season” (U18). A third year of patient enrollment is needed to obtain the sample size necessary to meet the objectives of this study. Despite good enrollment during the second year of the study, 2011-12, few influenza infections were identified. Flu activity was low through the U.S. Also, the number of LRTI hospitalizations was lower than previous years. An additional year would allow a larger sample size. Based on past performance, if current enrollment rates continue and there is 10-15% influenza, sample size will be met. |
Additional Information
| Agency Name:: | Centers for Disease Control and Prevention |
| Description:: | The purpose of the program is to continue the objectives of FOA IP10-007 to determine the effectiveness of empiric influenza antiviral therapy, in addition to empiric antibiotic therapy, for hospitalized CAP patients, and other patients with lower respiratory tract illness, during the periods when influenza viruses are circulating in the community. This program addresses the Healthy People 2020 focus area(s) of Immunization and Infectious Diseases. |
| Link to Additional Information:: | |
| Grantor Contact Information:: | If you have difficulty accessing the full announcement electronically, please contact: |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| Synopsis 1 |
Package Status
Below are CLOSED Opportunity Package(s) no longer available for this Funding Opportunity:
Package No: 1
| Assistance Listings: | 93.185 |
| Competition ID: | NCIRD-R |
| Competition Title: | Effectiveness of Empiric Antiviral Treatment for Hospitalized Community Acquired Pneumonia during th |
| Opportunity Package ID: | PKG00135010 |
| Opening Date: | Jul 30, 2012 |
| Closing Date: | Aug 10, 2012 |
| Agency Contact Information:: | CDC |
| Who Can Apply:: | Organization Applicants |
| mendatory_forms |
SF424 (R & R) [V1.2] Project/Performance Site Location(s) [V1.4] Research And Related Other Project Information [V1.3] Research And Related Senior/Key Person Profile (Expanded) [V1.2] Research & Related Budget [V1.1] PHS 398 Cover Page Supplement [V1.4] PHS 398 Research Plan [V1.3] PHS 398 Checklist [V1.3] |
| optional_forms |
R & R Subaward Budget Attachment(s) Form 5 YR 30 ATT [V1.2] PHS Cover Letter [V1.2] |
Packages
| Assistance Listings | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions | Who Can Apply: | |
|---|---|---|---|---|---|---|---|---|
| 93.185 | NCIRD-R | Effectiveness of Empiric Antiviral Treatment for Hospitalized Community Acquired Pneumonia during th | PKG00135010 | Jul 30, 2012 | Aug 10, 2012 | View | CDC | Organization Applicants |